ProstaPilot: A Comparative Study of Biparametric Magnetic Resonance Imaging Versus Prostate-specific Antigen as a Screening Test for Prostate Cancer
We compared a blood test for PSA (prostate-specific antigen) and an MRI scan (magnetic resonance imaging) for detection of prostate cancer in men aged 50-69 years. We found that MRI scans may reduce the number of biopsies that need to be performed for cancer diagnosis while increasing the detection rate for cancers that are significant.
Authors
- Jan Křístek (ORCID: https://orcid.org/0000-0003-0029-7708)
- Miloš Pacal
- Roman Hrabec
- Kateřina Hejcmanová
- Michal Uher (ORCID: https://orcid.org/0000-0001-8970-5928)
- David Miklánek
- Ondřej Ngo (ORCID: https://orcid.org/0000-0003-0589-8991)
- Alexandr Poprach (ORCID: https://orcid.org/0000-0003-4698-9195)
- Karel Hejduk (ORCID: https://orcid.org/0000-0001-6215-4679)
- Michal Standara (ORCID: https://orcid.org/0000-0003-1935-3538)
- Michal Staník (ORCID: https://orcid.org/0000-0002-5123-024X)
- Ondřej Májek
Institutions
- Masaryk University (CZ)
- Masaryk Memorial Cancer Institute (CZ)
- Institute of Health Information and Statistics (CZ)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1016/j.euros.2025.03.016
- Citations
- 2
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04